Xiaosong Zhang; Weihong Chen; Xinxin Zhu; Hui Bi; Qingping Zhao; Yunfeng Fu; Lina Zhang; Chunmei Zhang; Ning Huang; Xiaosong Zhang; Weihong Chen; Xinxin Zhu; Hui Bi; Qingping Zhao; Yunfeng Fu; Lina Zhang; Chunmei Zhang; Ning Huang

doi:10.46234/ccdcw2023.038

[1]

International Agency for Research on Cancer. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020. https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf. [2022-2-28].

[2]

Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Center 2022;2(1):1 − 9. http://dx.doi.org/10.1016/j.jncc.2022.02.002.

[3]

Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. The IARC perspective on cervical cancer screening. N Engl J Med 2021;385(20):1908 − 18. http://dx.doi.org/10.1056/NEJMsr2030640.

[4]

Xiao Y, Chang SF, Sun JC, Zhang XY, Dan Y, Tang YH. Clinical value of colposcopy with selective thinprep cytology test for opportunistic cervical cancer screening. J Chongqing Med Univ 2019;44(1):30-4. http://cyxb.ijournals.cn/cqydxb/article/abstract/201901007. (In Chinese).

[5]

Bao HL, Ma L, Zhao YX, Song B, Di JL, Wang LH, et al. Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study. Cancer Commun 2022;42(3):191 − 204. http://dx.doi.org/10.1002/cac2.12256.

[6]

Bchtawi AK, Saritas S, Schledermann D, dePont Christensen R, Jochumsen KM. Screening history and FIGO-stages among Danish women with cervical cancer in 2012–2014: a register-based study. Sci Rep 2019;9(1):20390. http://dx.doi.org/10.1038/s41598-019-56833-w.

[7]

Benard VB, Jackson JE, Greek A, Senkomago V, Huh WK, Thomas CC, et al. A population study of screening history and diagnostic outcomes of women with invasive cervical cancer. Cancer Med 2021;10(12):4127 − 37. http://dx.doi.org/10.1002/cam4.3951.

[8]

Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: past, present, and future. Sex Med Rev 2020;8(1):28 − 37. http://dx.doi.org/10.1016/j.sxmr.2019.09.005.

[9]

Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health 2022;10(8):e1115 − 27. http://dx.doi.org/10.1016/S2214-109X(22)00241-8.

[10]

Zhang M, Zhong YJ, Wang LM, Bao HL, Huang ZJ, Zhao ZP, et al. Cervical cancer screening coverage-China, 2018-2019. China CDC Wkly 2022;4(48):1077 − 82. http://dx.doi.org/10.46234/ccdcw2022.217.

[11]

National Centre for Women and Children’s Health, Chinese Center for Disease Control and Prevention. Information management manual of cervical and breast cancer screening. 2022. https://www.chinawch.org.cn/tzgg2021/tzgg2_2021/202210/P020221024556061863794.pdf. (In Chinese).